Dyslipidemia – It has an outsized presence in correctional health settings and can be tough to manage for those patients. Fortunately for providers across all settings, managing dyslipidemia is becoming more streamlined with a new set of guidelines from the American College of Cardiology/American Heart Association.

Chris is here to break down these 2026 dyslipidemia guidelines, highlighting updated risk assessment tools, cholesterol targets, and evidence-based therapies while offering practical guidance tailored to correctional healthcare.

To see Chris' handy dyslipedmia pocket guide, sign up for an account at opticsclinical.com.

Before that, Chris brings us up to speed with medication news

Baxfendy- A brand new aldosterone synthase inhibitor

Ozempic- Oral tablets and the “retirement” of Rybelsus

Hepcludex- Accelerated approval for the only Hep D drug in the US

Orphines- Another synthetic opioid to look out for

And to finish things out, we look at the amazing story of statins and their unlikely origin.

Link to the full show notes with references for further reading.

Sponsor Links:

www.opticsclinical.com

www.sapphire-health.com

Music in this Episode:

The Retro Synth by Art Haiz

Vitals & Headlines (Suno AI)

Breezy Thoughts (Suno AI)

Trivia Time Ticker (Suno AI)